Fiche centre
Nantes University hospital
Nantes — France
Essais liés4clinical trials
VilleNanteslocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06091865
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Odronextamab | Cancer | Phase 3 | NCT06091865 | OLYMPIA-3 — A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma | RECRUITING |
| colonoscopy or rectosigmoidoscopy | Parkinson | Non applicable | NCT01353183 | ColoBioParker — Analysis of the Enteric Nervous System Using Colonic Biopsies | COMPLETED |
| Tys at Home — Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis | SEP | À vérifier | NCT04777539 | Tys at Home — Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple Sclerosis | COMPLETED |
| Ocrelizumab | SEP | Phase 3 | NCT05210621 | CONSONANCE EX — LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB | ACTIVE_NOT_RECRUITING |